THROMBOTIC THROMBOCYTOPENIC PURPURA, ACQUIRED

Clinical trials for THROMBOTIC THROMBOCYTOPENIC PURPURA, ACQUIRED explained in plain language.

Never miss a new study

Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA, ACQUIRED trials appear

Sign up with your email to follow new studies for THROMBOTIC THROMBOCYTOPENIC PURPURA, ACQUIRED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Custom drug timing tested for dangerous blood clotting disease

Disease control Terminated

This study tested whether adjusting the duration of a drug called caplacizumab based on blood test results could effectively treat acquired thrombotic thrombocytopenic purpura (aTTP), a rare and serious blood clotting disorder. The trial involved 58 adults with aTTP and monitored…

Matched conditions: THROMBOTIC THROMBOCYTOPENIC PURPURA, ACQUIRED

Phase: PHASE2 • Sponsor: University Hospital, Rouen • Aim: Disease control

Last updated Apr 04, 2026 06:50 UTC

THROMBOTIC THROMBOCYTOPENIC PURPURA, ACQUIRED

Get alerted when new THROMBOTIC THROMBOCYTOPENIC PURPURA, ACQUIRED trials appear

Custom drug timing tested for dangerous blood clotting disease